Try a new search

Format these results:

Searched for:

person:gonzas15

Total Results:

35


Immunoglobulin g4-associated cholangitis can mimic cholangiocarcinoma on radiologic and cholangioscopic findings

Gonzalez, Susana; Moreira, Roger Klein; Verna, Elizabeth C; Samstein, Benjamin; Poneros, John M
PMCID:3977646
PMID: 24711772
ISSN: 1554-7914
CID: 2674572

Characteristics, goals, and motivations of applicants pursuing a fourth-year advanced endoscopy fellowship

Trindade, Arvind J; Gonzalez, Susana; Tinsley, Andrew; Kim, Michelle; Dimaio, Christopher J
BACKGROUND: The number of applications to advanced endoscopy fellowships has increased in past years. There is limited knowledge regarding why gastroenterology fellows pursue interventional/advanced endoscopy (AE) as a career. OBJECTIVE: To explore the characteristics, goals, and motivations of applicants applying for AE fellowships. DESIGN: A total of 101 applicants of the 2011 AE fellowship match were sent a survey via electronic mail 4 weeks after the match. PARTICIPANTS: A total of 65 applicants participated. INTERVENTION: Study questionnaire. RESULTS: The response rate was 64.4% (95% certainty +/- 5%). By the first year of gastroenterology fellowship, 67% had decided to apply for an AE fellowship. Half stated that pursuing a career in AE was a difficult decision; primary concerns included the additional year of training and the delay in income. A total of 69% of applicants intended to pursue academics. Applicants listed endoscopic procedures (92%), exposure to mentors in the field (46%), and demand for the skill set (43%) as the most significant sources of motivation in pursuing AE. Influential factors in an applicant's decision to choose a program included high procedure volume (69%), reputation of the program (63%), and a desirable geographic location (61%). Applicants who reported difficulty in choosing AE as a career were less inclined to pursue academia as compared with those with no difficulty deciding (54.8% vs 84.4%; P = .006). These same applicants were similarly less motivated to pursue research (3.1% vs 34.3%; P = .002). Applicants who favored academia versus private practice listed mentors in the field (54% vs 25%; P = .031) and research interest (27.3% vs 0%; P = .012) as significant factors. LIMITATIONS: One-year sample of applicants. CONCLUSION: Although a majority of applicants decided to pursue careers in AE during the first year of gastroenterology fellowship, making the decision was difficult for half of the applicants. Motivations for choosing AE as a career differed among applicants interested in academics versus private practice.
PMID: 23078920
ISSN: 1097-6779
CID: 2674532

Blood Urea Nitrogen as a Predictor of Development of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Case-Control Study [Meeting Abstract]

Kushner, Tatyana; Majd, Nazanin; Sigel, Keith; Liverant, Mitchell L; Wong, Serre-Yu; Patel, Kalpesh K; Gonzalez, Susana
ISI:000304328000122
ISSN: 0016-5107
CID: 2674692

Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures

Gonda, Tamas A; Glick, Michael P; Sethi, Amrita; Poneros, John M; Palmas, Walter; Iqbal, Shahzad; Gonzalez, Susana; Nandula, Subhadra V; Emond, Jean C; Brown, Robert S; Murty, Vundavalli V; Stevens, Peter D
BACKGROUND: The diagnosis of indeterminate biliary strictures is limited because of the low sensitivity of cytology. However, an accurate diagnosis of malignancy is critical in the management of patients with suspected biliary malignancy. Testing for chromosomal aneuploidy by fluorescence in situ hybridization (FISH) may increase the yield. OBJECTIVE: To evaluate the diagnostic accuracy of FISH in indeterminate biliary strictures and the additional value of including deletion of 9p21 (p16) in the diagnostic criteria of malignant biliary strictures. DESIGN: Retrospective review. SETTING: Academic medical center. PATIENTS: This study involved 76 consecutive patients who were seen for the evaluation of indeterminate strictures at our institution. These patients were screened, and 50 patients with either a final pathologic diagnosis or >/= 12 months' conclusive follow-up were included in the analysis. MAIN OUTCOME MEASUREMENTS: Sensitivity, specificity, and area under the curve (AUC) analysis of cytology alone compared with the presence of FISH polysomy versus FISH polysomy and 9p21 deletion. RESULTS: The presence of increased copy numbers (polysomy) of chromosome 3, 7, or 17 by FISH increased the sensitivity of brush cytology from 21% to 58%, and when the presence of 9p21 deletion was included, the sensitivity increased to 89%. The specificity of FISH was 97% (vs 100% for cytology). The accuracy of cytology combined with FISH polysomy (AUC = 0.93) or p16 deletion was significantly greater than the accuracy of cytology alone (AUC 0.6; P < .001) or even cytology combined with FISH polysomy (AUC = 0.77; P
PMID: 22100297
ISSN: 1097-6779
CID: 2674552

Detection of Colonic Adenomas Using a Low-Cost, High Resolution Microendoscope: Assessment of Accuracy and Interobserver Variability [Meeting Abstract]

Chang, Shannon S; Shukla, Richa; Lee, Michelle H; Vila, Peter M; Han, Hyosun; Kedia, Prashant; Lewis, Jeffrey R; Gonzalez, Susana; Kim, Michelle K; Polydorides, Alexandros D; Richards-Kortum, Rebecca; Anandasabapathy, Sharmila
ISI:000306994301611
ISSN: 0016-5085
CID: 2198002

Physician knowledge and appropriate utilization of computed tomographic colonography in colorectal cancer screening

Chang, Matthew S; Shah, Jessica P; Amin, Sunil; Gonzalez, Susana; Prowda, Joan C; Cheng, Joan M; Verna, Elizabeth C; Rockey, Don C; Frucht, Harold
GOALS: To assess physician understanding of computed tomographic colonography (CTC) in colorectal cancer (CRC) screening guidelines in a pilot study. BACKGROUND: CTC is a sensitive and specific method of detecting colorectal polyps and cancer. However, several factors have limited its clinical availability, and CRC screening guidelines have issued conflicting recommendations. STUDY: A web-based survey was administered to physicians at two institutions with and without routine CTC availability. RESULTS: 398 of 1655 (24%) participants completed the survey, 59% was from the institution with routine CTC availability, 52% self-identified as trainees, and 15% as gastroenterologists. 78% had no personal experience with CTC. Only 12% was aware of any current CRC screening guidelines that included CTC. In a multiple regression model, gastroenterologists had greater odds of being aware of guidelines (OR 3.49, CI 1.67-7.26), as did physicians with prior CTC experience (OR 4.81, CI 2.39-9.68), controlling for institution, level of training, sex, and practice type. Based on guidelines that recommend CTC, when given a clinical scenario, 96% of physicians was unable to select the appropriate follow-up after a CTC, which was unaffected by institution. CONCLUSIONS: Most physicians have limited experience with CTC and are unaware of recent recommendations concerning CTC in CRC screening.
PMID: 21318376
ISSN: 1432-0509
CID: 2674522

Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation

Vaccaro, Benjamin J; Gonzalez, Susana; Poneros, John M; Stevens, Peter D; Capiak, Kristina M; Lightdale, Charles J; Abrams, Julian A
BACKGROUND: Radiofrequency ablation (RFA) is an effective means of eradicating Barrett's esophagus (BE), both with and without associated dysplasia. Several studies have documented high initial success rates with RFA. However, there is limited data on IM detection rates after eradication. AIMS: To determine the rate of detection of intestinal metaplasia (IM) after successful eradication of Barrett's esophagus. METHODS: BE patients with and without dysplasia who had undergone RFA were retrospectively identified. Only those who had complete eradication as documented on the initial post-ablation endoscopy, and had minimum two surveillance endoscopies, were included in the analyses. Clinical, demographic, and endoscopic data were collected. Cumulative incidence of IM detection was calculated by the Kaplan-Meier method. RESULTS: Forty-seven patients underwent RFA and had complete eradication of Barrett's epithelium. The majority of patients were male (76.6%), and the mean age was 64.2 years. The cumulative incidence of newly detected IM at 1 year was 25.9% (95% CI 15.1-42.1%). Dysplasia was detected at the time of recurrence in four patients, and all cases were detected at the GE junction in the absence of visible BE. Patients with recurrent IM had longer baseline segments of BE (median, 4 cm vs. 2 cm, p = 0.03). CONCLUSIONS: The rate of detection of new IM is high in patients who have undergone successful eradication of BE by RFA. Additionally, dysplasia can recur at the GE junction in the absence of visible BE. Future studies are warranted to identify those patients at increased risk for the development of recurrent intestinal metaplasia.
PMCID:3144139
PMID: 21468652
ISSN: 1573-2568
CID: 2674542

Clinical and genetic characterization of classical forms of familial adenomatous polyposis: a Spanish population study

Rivera, B; Gonzalez, S; Sanchez-Tome, E; Blanco, I; Mercadillo, F; Leton, R; Benitez, J; Robledo, M; Capella, G; Urioste, M
BACKGROUND: Classical familial adenomatous polyposis (FAP) is characterized by the appearance of >100 colorectal adenomas. PATIENTS AND METHODS: We screened the APC and MUTYH genes for mutations and evaluated the genotype-phenotype correlation in 136 Spanish classical FAP families. RESULTS: APC/MUTYH mutations were detected in 107 families. Sixty-four distinct APC point mutations were detected in 95 families of which all were truncating mutations. A significant proportion (39.6%) had not been previously reported. Mutations were spread over the entire coding region and great rearrangements were identified in six families. Another six families exhibited biallelic MUTYH mutations. No APC or MUTYH mutations were detected in 29 families. These APC/MUTYH-negative families showed clinical differences with the APC-positive families. A poor correlation between phenotype and mutation site was observed. CONCLUSIONS: Our results highlight that a broad approach in the genetic study must be considered for classical FAP due to involvement of both APC and MUTYH and the heterogeneous spectrum of APC mutations observed in this Spanish population. The scarcely consistent genotype-phenotype correlation does not allow making specific recommendations regarding screening and management. Differences observed in APC/MUTYH-negative families may reflect a genetic basis other than mutations in APC and MUTYH genes for FAP predisposition.
PMID: 20924072
ISSN: 1569-8041
CID: 2674592

Randomized comparison of 3 different-sized biopsy forceps for quality of sampling in Barrett's esophagus

Gonzalez, Susana; Yu, Woojin M; Smith, Michael S; Slack, Kristen N; Rotterdam, Heidrun; Abrams, Julian A; Lightdale, Charles J
BACKGROUND: Several types of forceps are available for use in sampling Barrett's esophagus (BE). Few data exist with regard to biopsy quality for histologic assessment. OBJECTIVE: To evaluate sampling quality of 3 different forceps in patients with BE. DESIGN: Single-center, randomized clinical trial. PATIENTS: Consecutive patients with BE undergoing upper endoscopy. INTERVENTIONS: Patients randomized to have biopsy specimens taken with 1 of 3 types of forceps: standard, large capacity, or jumbo. MAIN OUTCOME MEASUREMENTS: Specimen adequacy was defined a priori as a well-oriented biopsy sample 2 mm or greater in diameter and with at least muscularis mucosa present. RESULTS: A total of 65 patients were enrolled and analyzed (standard forceps, n = 21; large-capacity forceps, n = 21; jumbo forceps, n = 23). Compared with jumbo forceps, a significantly higher proportion of biopsy samples with large-capacity forceps were adequate (37.8% vs 25.2%, P = .002). Of the standard forceps biopsy samples, 31.9% were adequate, which was not significantly different from specimens taken with large-capacity (P = .20) or jumbo (P = .09) forceps. Biopsy specimens taken with jumbo forceps had the largest diameter (median, 3.0 mm vs 2.5 mm [standard] vs 2.8 mm [large capacity]; P = .0001). However, jumbo forceps had the lowest proportion of specimens that were well oriented (overall P = .001). LIMITATIONS: Heterogeneous patient population precluded dysplasia detection analyses. CONCLUSIONS: Our results challenge the requirement of jumbo forceps and therapeutic endoscopes to properly perform the Seattle protocol. We found that standard and large-capacity forceps used with standard upper endoscopes produced biopsy samples at least as adequate as those obtained with jumbo forceps and therapeutic endoscopes in patients with BE.
PMCID:3144471
PMID: 21034895
ISSN: 0016-5107
CID: 847442

Prospective study of the role of duodenal bulb biopsies in the diagnosis of celiac disease

Gonzalez, Susana; Gupta, Anupama; Cheng, Jianfeng; Tennyson, Christina; Lewis, Suzanne K; Bhagat, Govind; Green, Peter H R
BACKGROUND: Studies have demonstrated that villous atrophy in celiac disease is patchy and have suggested that duodenal bulb biopsies aid in diagnosis. OBJECTIVE: To determine the role of the addition of duodenal bulb biopsies to distal duodenum (D2) biopsies in the diagnosis of celiac disease. DESIGN: Prospective, case-control study. SETTING: Tertiary referral hospital. PATIENTS: Patients undergoing upper endoscopy with biopsy for diagnosis or follow-up of celiac disease and control patients. INTERVENTIONS: Blinded review of duodenal biopsy samples. MAIN OUTCOME MEASUREMENTS: Increasing the yield as well as accuracy of the histologic diagnosis of celiac disease with the addition of bulb biopsies. RESULTS: Of 128 patients enrolled in the study, 67 had celiac disease. Of 1079 biopsy specimens, only 319 (30%) were adequate for complete histologic analysis, resulting in 40 celiac patients and 40 control patients for analysis. Of the 40 celiac patients, 35 (87.5%) had atrophy in either the bulb or D2, 30 (75%) exhibited atrophy at both sites with an identical grade of atrophy seen in 18 patients (45%). Fourteen patients (35%) had identical types of Marsh lesions in both biopsy sites. Twelve patients (30%) had atrophy detected in the bulb, D2, or both, but lacked intraepithelial lymphocytes and thus could not be assigned a Marsh grade. Five patients (13%) had a diagnosis of celiac disease based on findings in the bulb biopsy only. LIMITATIONS: Small sample size and study performed in an academic medical center. CONCLUSIONS: Our study confirms the patchy nature of villous atrophy as well as intraepithelial lymphocytosis in biopsy specimens from individuals with celiac disease. Adding duodenal bulb biopsies to our sampling regimen increased the diagnostic yield of celiac disease.
PMID: 20883853
ISSN: 1097-6779
CID: 2674512